| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Revenue | $342.3M | +19.4% |
| Cost of Revenue | $272.6M | +19.9% |
| Gross Profit | $69.6M | +17.4% |
| R&D Expense | $15.0M | +47.9% |
| SG&A Expense | $48.0M | -24.9% |
| Operating Income | $6.6M | +144.4% |
| Pre-tax Income | -$2.3M | +91.1% |
| Income Tax | $240K | +146.1% |
| Net Income | -$6.8M |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.8M | +2.5% |
| Accounts Receivable | $54.3M | -17.6% |
| Inventory | $14.5M | -5.3% |
| Current Assets | $132.1M | -9.8% |
| Total Assets | $313.8M | -0.9% |
| Current Liabilities | $154.3M | +7.0% |
| Long-term Debt | $39.8M | -0.7% |
| Line Item | 2024-12-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.5M | +83.1% |
| Capital Expenditures | $7.9M | -7.9% |
| Investing Cash Flow | -$11.2M | -6.8% |
| Financing Cash Flow | -$6.8M | +39.5% |
| Free Cash Flow | $10.5M | +619.0% |
| +77.9% |
| EPS (Basic) | -$0.14 | +79.4% |
| EPS (Diluted) | -$0.14 | +79.4% |
| Total Liabilities |
| $250.3M |
| -2.3% |
| Stockholders' Equity | $57.6M | +7.2% |